News

China Medicine has reported that through its wholly-owned subsidiary, Konzern, it has signed an equity transfer agreement to acquire 100% of equity interests in Sinoform. Under the terms

FDA has sent a warning letter to Procter & Gamble notifying the company that its Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally

AcelRx Pharmaceuticals (AcelRx) has completed an end-of-phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab dosage form, which enables

Amgen has published the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp?? Therapy), a randomised, double-blind and placebo-controlled, phase 3 pivotal study of patients with

Total Nutraceutical Solutions (TNS) has started evaluating several proprietary mushroom compounds for activity in controlling the development of Alzheimer’s Disease (AD). Model Biosystems (MBS) has informed TNS that

CCBR-SYNARC has expaned its Electronic Data Capture (EDC) capabilities for use in imaging clinical trials. With the release of the enhanced SynarcConnect service, SYNARC has further improved its

Xybion Medical, the developer of Pristima, has reported that Calvert Labs has licensed, validated and placed Pristima into production. Using Xybion’s Standard Validation Package to accelerate its implementation

Interleukin will fulfill and process all Inherent Health genetic tests through the company’s CLIA-certified laboratory in Waltham, Massachusetts. Amway Global will assist with marketing, implementation and technical operations

Octapharma Group and Fresenius Kabi have signed a license, development and supply agreement regarding the use of latter’s HESylation Technology to develop a HESylated recombinant protein. Under the